Taking Advantage of the Senescence-Promoting Effect of Olaparib after X-ray and Proton Irradiation Using the Senolytic Drug, ABT-263.

Huart, Camille; Fransolet, Maude; Demazy, Catherine; Le Calvé, Benjamin; Lucas, Stéphane; Michiels, Carine; Wéra, Anne-Catherine

Huart, Camille; Fransolet, Maude; Demazy, Catherine; Le Calvé, Benjamin; Lucas, Stéphane; Michiels, Carine; Wéra, Anne-Catherine.

Afiliação

Huart C; Cellular Biology Research Unit (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.
Fransolet M; Cellular Biology Research Unit (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.
Demazy C; Cellular Biology Research Unit (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.
Le Calvé B; Cellular Biology Research Unit (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.
Lucas S; Laboratory of Analysis by Nuclear Reaction (LARN), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.
Michiels C; Cellular Biology Research Unit (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.
Wéra AC; Cellular Biology Research Unit (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur (UNamur), 5000 Namur, Belgium.

Cancers (Basel) ; 14(6)2022 Mar 12.

Article em En | MEDLINE | ID: mdl-35326611

Palavras-chave

PARP; X-ray radiation; cancer; proton radiation; senescence; senolytics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google